Jake Becraft is a synthetic biologist and biotech entrepreneur serving as co-founder and CEO of Strand Therapeutics, where he leads the development of programmable mRNA medicines for cancer and other diseases. He holds a PhD in Biological Engineering from MIT and a BS in Chemical and Biomolecular Engineering from the University of Illinois Urbana-Champaign.
Co-founder & CEO
Leads the development of programmable mRNA therapeutics designed to control protein expression with cellular and tissue specificity. Co-founded the company while completing doctoral research at MIT.
Investment Advisor
PhD in Biological Engineering
BS in Chemical and Biomolecular Engineering
